Renal anemia
Information
- Disease name
- Renal anemia
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03388385 | Active, not recruiting | Phase 4 | Acute Effects of Intravenous Iron on Oxidative Stress and Endothelial Dysfunction in Non-dialysis CKD | September 20, 2017 | December 20, 2022 |
| NCT05085275 | Active, not recruiting | Phase 3 | Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease | March 30, 2022 | August 2024 |
| NCT04408820 | Active, not recruiting | Post-marketing Surveillance of EVRENZO® Tablets (Roxadustat) in Patients With Renal Anemia | June 1, 2020 | March 31, 2025 | |
| NCT05265325 | Active, not recruiting | Phase 2 | A Study of AND017 to Treat Anemia in Chronic Kidney Disease Patients on Dialysis | May 3, 2023 | April 2024 |
| NCT01306409 | Completed | Phase 4 | Neocytolysis in the Treatment of Renal Anemia With Erythropoieses Stimulating Agents (ESA) | January 2011 | October 2011 |
| NCT01543477 | Completed | Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia | July 7, 2010 | April 29, 2020 | |
| NCT02041208 | Completed | Variability of Hemoglobin Levels After Kidney Transplantation | March 2012 | October 2012 | |
| NCT02136563 | Completed | Renal Prognosis in Chronic Kidney Disease Patients With Hyporesponsive Anemia to Erythropoiesis Stimulating Agents | April 2014 | August 2019 | |
| NCT02299661 | Completed | Phase 1 | Pilot PK/PD Study of DS-1093a in Patients With Chronic Kidney Disease | November 2014 | May 2015 |
| NCT02708914 | Completed | Phase 3 | Study to Compare the Safety and Efficacy of UB-851 and Eprex® | March 2016 | October 2021 |
| NCT02947438 | Completed | Phase 3 | Biosimilar Erythropoietin in Anaemia Treatment (Maintenance Phase Study) | December 2015 | October 9, 2021 |
| NCT04227158 | Completed | The Association Between the Distributions MCH and RBC, and Mortality in Hemodialysis Patients | April 20, 2020 | August 20, 2020 | |
| NCT04454879 | Completed | Phase 4 | Different Doses of Roxadustat Treatment for Anemia in Peritoneal Dialysis Patients | July 1, 2020 | August 3, 2021 |
| NCT00298441 | Completed | Phase 4 | Efficacy of Intravenous Iron Administration in Hemodialysis Patients | June 2005 | March 2007 |
| NCT00322413 | Completed | Phase 3 | Comparison of Epoetin Alfa and Epoetin Omega in Anemic Dialysis Patients:Results of Efficacy Trial | January 1997 | April 1997 |
| NCT00456053 | Completed | Phase 2 | A Randomized Study of the Safety and Efficacy of FG-2216 in Subjects With Renal Anemia Not Requiring Dialysis and Not Receiving Recombinant Human Erythropoietin | December 2005 | July 2007 |
| NCT00717366 | Completed | Phase 2 | Study to Determine Optimum Intravenous Starting Dose of MIRCERA for Treatment of Pediatric Participants With Anemia and Chronic Kidney Disease on Hemodialysis | July 2008 | March 2016 |
| NCT05035641 | Completed | Phase 2 | A Study of AND017 to Treat Anemia in Non-dialysis-Dependent Chronic Kidney Disease (NDD-CKD) Patients | October 18, 2021 | July 24, 2023 |
| NCT05864261 | Completed | Phase 4 | Pharmacokinetics Comparison Study of JT1801 and NESP® After Single Dose Administration in Chinese Health Male Volunteers | May 15, 2023 | August 28, 2023 |
| NCT05951192 | Completed | Phase 4 | A Prospective Interventional Study Assessing the Clinical and Operational Effectiveness of Transitioning From Mircera to Daprodustat for the Treatment of Anemia in End Stage Kidney Disease | July 1, 2023 | February 14, 2024 |
| NCT05629598 | Recruiting | Phase 2 | A Study of PEG-EPO Injection (CHO Cells) for Maintenance Therapy of Patients With Renal Anemia . | April 13, 2022 | August 16, 2023 |
| NCT05970172 | Recruiting | Phase 3 | A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease | January 16, 2024 | June 30, 2026 |
| NCT04899661 | Recruiting | A Study to Learn More About the Long-term Safety and Effectiveness of Molidustat as a Treatment for Japanese Men and Women With Renal Anemia | August 6, 2021 | September 30, 2027 | |
| NCT04925661 | Unknown status | Phase 1 | HEC53856 Phase Ib Study in Patients With Non-dialysis Renal Anemia | September 29, 2021 | May 10, 2023 |
| NCT04775615 | Unknown status | Phase 1 | Multi-dose, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DDO-3055 Tablets in Healthy Subjects. | March 17, 2021 | June 1, 2021 |
| NCT04360902 | Unknown status | N/A | Assessment of an Anemia Model Predictive Controller for Anemia Management in Hemodialysis Patients | January 8, 2020 | December 2021 |
| NCT03480178 | Unknown status | Renal Anemia Refractory to Erythropoietin | January 2019 | May 2019 |